By Claire Keeton - 19 April 2021 - 10:34 The pause in the rollout of Johnson & Joh"> By Claire Keeton - 19 April 2021 - 10:34 The pause in the rollout of Johnson & Joh" property="og:description"> By Claire Keeton - 19 April 2021 - 10:34 The pause in the rollout of Johnson & Joh">
J&J jabs expected to resume this week Claire Keeton"> By Claire Keeton - 19 April 2021 - 10:34 The pause in the rollout of Johnson & Johnson's Covid-19 vaccine to investigate a very rare blood clotting disorder is likely to be lifted soon. File photo. Image: Dado Ruvic/Reuters Prof Glenda Gray, co-principal investigator of the Sisonke implementation study, which is providing health-care workers with Covid-19 J&J vaccines, said on Monday morning the suspension of the inoculations is expected to be lifted soon. The vaccinations were paused by the SA Health Products Regulatory Authority (Sahpra) on Tuesday night last week, the same day the US Food and Drug Administration paused its J&J rollout because of extremely rare and severe blood clots detected in six out of 6.8 million Americans vaccinated.